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ntroduction
Feline immunodeﬁciency virus (FIV) is a widespread
hogen of the domestic cat and infection results in a
gressive immune dysfunction similar to AIDS in human
unodeﬁciency virus (HIV) infection. Since its discov-
in 1986 from a cat with an immunodeﬁciency like
drome (Pedersen et al., 1987), FIV has been recognized
ely as the feline equivalent of human immunodeﬁ-
cy virus (HIV) and both viruses share signiﬁcant
physical, biochemical and pathogenic features (Johnson
et al., 1994). Such are the similarities between FIV and HIV
that FIV serves as a valuable animal model for both
prophylactic and therapeutic studies of HIV (Elder and
Phillips, 1995) as well as being the only non-primate
lentivirus that induces an AIDS-like syndrome in its natural
host (reviewed in Willett et al., 1997).
Like other retroviruses, FIV has high mutation rate,
mainly due to the error-prone reverse transcriptase
(Shankarappa et al., 1999); accordingly, diverse viral
variants emerge continually in the infected host. Since the
env gene is the key determinant of viral diversity among FIV
(Olmsted et al., 1989), FIV phylogeny studies have focussed
mainly on env sequences. According to the nucleotide
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A B S T R A C T
Feline immunodeﬁciency virus (FIV) is a signiﬁcant pathogen of domestic andnon-domestic
felids worldwide. In domestic cats, FIV is classiﬁed into ﬁve distinct subtypes (A–E) with
subtypes A and B distributed most widely. However, little is known about the degree of
intrasubtype viral diversity and thismay prove critical in determiningwhethermonovalent
vaccines are likely to protect against FIV strains within a single subtype. Here, we
characterise novel env sequences from 47 FIV strains recovered from infected cats in the
United Kingdom and its environs. Phylogenetic analyses revealed that all bar one sequence
belonged to subtype A, the predominant subtype inWestern Europe. A single sequencewas
identiﬁed as a likely subtype A/C recombinant, intriguing given that subtype C does not
appear to exist in either the UK or NorthWestern Europe and suggestive of a recombination
event predating its introduction into the UK. Subtype A strains from the UK were not
signiﬁcantly differentiated from representative subtype A isolates found elsewhere
suggesting multiple introductions of FIV into the country. Divergence among isolates
was comparable to that observed for subtype A isolatesworldwide, indicating that FIV in the
UK covers the full spectrum of subtype A diversity seen globally. This study demonstrates
that while subtype A is predominant in the UK, novel introductions may result in the
emergence of novel subtypes or intersubtype recombinants, potentially circumventing
vaccine strategies. However, the dominance of subtype A suggests that thedevelopment of a
regional or subtype-speciﬁc protective vaccine for the UK could be achievable.
 2011 Elsevier B.V.
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A. Samman et al. / Veterinary Microbiology 150 (2011) 239–247240sequence diversity of the V3–V5 region of env, FIV is
classiﬁed currently into ﬁve distinct phylogenetic subtypes,
designated A to E (Sodora et al., 1994; Pecoraro et al., 1996);
subtypes A and B are the most commonly occurring
worldwide (Martins et al., 2008). Furthermore, similar to
HIV-1, several inter-subtype FIV recombinants have been
recognized in natural populations following co-infection;
inter-subtype recombinants A/B, A/C and B/D have been
identiﬁed (Bachmann et al., 1997; Hayward and Rodrigo,
2008).
Phylogenetic studies on FIV sequences have revealed
signiﬁcant heterogeneity (up to 30%) in the sequence of the
env gene of FIV isolates worldwide (Burkhard and Dean,
2003) similar to that estimated for HIV-1 (Rong et al.,
2007). Subtype A isolates are common in Australia, New
Zealand, western United States, South Africa and north-
western Europe (Bachmann et al., 1997; Steinrigl and
Klein, 2003; Kann et al., 2006a,b, 2007a,b). Subtype B
isolates have been identiﬁed in the central and eastern
United States, central Europe, Brazil and eastern Japan
(Sodora et al., 1994; Kakinuma et al., 1995; Pistello et al.,
1997; Nishimura et al., 1998; Steinrigl and Klein, 2003;
Martins et al., 2008). Subtype C has been recognized in
Canada, New Zealand and southeast Asia (Uema et al.,
1999; Nakamura et al., 2003; Reggeti and Bienzle, 2004;
Hayward et al., 2007). Finally, subtypes D and E are
infrequent but were identiﬁed originally in southwestern
Canada and Japan, and Argentina, respectively (Pecoraro
et al., 1996; Nishimura et al., 1998).
Such heterogeneity in env gene sequence poses
problems for the design of a broadly protective vaccine.
It has been reported previously that effective protection
was obtained following a homologous FIV challenge using
an inactivated whole virus vaccine, although, despite the
relative success of Fel-O-Vax against heterologous subtype
B isolates (Pu et al., 2005), protection did not extend to a
heterologous challenge (Dunham et al., 2006). Such
different outcomes highlight the impact of genetic
diversity on vaccine strategies against FIV and the
importance of assessing the genetic diversity of local
subtypes for vaccine development, or before introducing a
commercial vaccine to a particular geographical area.
Furthermore, identiﬁcation of the predominant strains in a
given region is necessary in order to develop appropriate
reagents for the molecular diagnosis of FIV infection
(Leutenegger et al., 1999; Hosie et al., 2002).
In order to understand better the degree of intrasubtype
viral diversity and the likelihood of a monovalent subtype A
FIV vaccine offering broad intrasubtype immunity, we
investigated the diversity of FIV within the United Kingdom,
a country in which FIV infection is prevalent and where
evidence to date suggests that a single viral subtype may
dominate.
2. Materials and methods
2.1. Blood samples, PBMC collection and DNA extraction
Blood samples were collected from 47 FIV sero-positive
samples from naturally infected cats submitted to the
Companion Animals Diagnostic Services at the University
of Glasgow. Cats were either companion pets or had been
placed into re-homing shelters. Blood samples were
centrifuged at 2000 rpm for 10min and the plasma
removed. Cell pellets were diluted in 1ml phosphate
buffered saline (PBS) and transferred to 20ml pre-warmed
red blood cell lysis buffer (0.88% NH4Cl, 10mM; pH 7.4)
and incubated at room temperature for 5min (red blood
cell lysis). The intact white blood cells were then pelleted
by centrifugation at 1000 rpm for 5min. The supernatant
was then discarded and the pelleted cells washed twice by
centrifugation through ice-cold PBSA buffer (1% bovine
serum albumin in PBS). 107 cells were used for DNA
extraction using QIAamp DNA Blood Mini Kit (Qiagen,
Crawley, UK), as per the manufacturer’s protocol.
2.2. Cloning of FIV env genes and nucleic acid sequence
determination
Env genes were ampliﬁed by using the polymerase
chain reaction (PCR) using a high ﬁdelity enzyme mix
(Expand High Fidelity PCR system, Roche Diagnostics Ltd.,
Burgess Hill, UK) and the degenerate primers 1F4 50-
TGTAATCAACG(CT)TTTGT(AG)TC-30 and 1R4 50-CCAA-
TA(AC)TCCCAGTCCACCCTT-30, primers we have found
previously to amplify laboratory strains of viral subtypes
A, B and C. The FIV env genes were then cloned into the
VR1012 eukaryotic expression vector (Vical Inc., San Diego,
CA, USA) and their nucleic acid sequences determined
using a BigDye Terminator v1.1 kit (Applied Biosystems,
Warrington, UK). Sequencing was performed by using
Applied Biosystems 3730xl genetic analyser. Raw chro-
matographic data were analysed by using ‘Contig Express’
sequence analysis software within the Vector NTI suite of
programs (Invitrogen Ltd., Paisley, UK).
2.3. Multiple sequence alignments and phylogenetic analyses
Nucleotide sequence analysis was performed on a 651
nucleotide fragment spanning theV3–V5regionof envgene.
The generated consensus included sequences of the 47
isolates included in the study, as well as selected
representative sequences from subtypes A–E. Multiple
alignment was performed using Clustal X (version 2.0)
(Larkin et al., 2007), followed by manual adjustment.
Alignments were translated and the resulting amino acid-
based alignments used as an exact guide for re-positioning
of improper gapping, particularly, where sequences were
different in length. Final alignments are available from the
authors upon request. DNA distance matrices were calcu-
lated with Paup (Swofford, 1993; Wilgenbusch and
Swofford, 2003) under a GTR+I+G model, selected in
Modeltest (Posada and Crandall, 1998) and parameterized
usingMaximumLikelihood (ML).ABayesianphylogenywas
estimated in MrBayes under a SDR06 model of evolution
(Huelsenbeck and Ronquist, 2001) based on two indepen-
dent runs of 10 Million generations, with samples taken
every 2000 generations. Because initial analyses indicated a
problemwith inﬂated branch lengths (Brown et al., 2010), a
ML tree (generated in Paup)was added as a starting tree and
the branch length prior was adjusted according to the
formula provided in (Brown et al., 2010).
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ermine their Euclidian distances. In order to test for any
tial patterns consistent with isolation by distance, the
relation between spatial and genetic ML distances was
essed based on a Mantel test using the geodist package
rogram R (http://cran.r-project.org).
Recombination analysis
A putative recombinant UK sequence (101070) was
essed for evidence of recombination using three
erent approaches: Bootscan analysis as implemented
the program Simplot, as well as and RDP and
eConv in program RDP3 (Martin et al., 2010). Along
h the 101070 sequence, consensus sequences for
h of the ﬁve subtypes (A–E) were included in the
lysis.
Nucleotide sequence accession numbers
GenBank accession numbers for control reference
uences in the phylogenetic analysis are: Subtype A:
001 (SwissZ2); M73964 (19K1M); M73965 (19K32);
31047 (ATVID02); AY221628 (CaONAB02); AY221629
ONAB03); AF531033 (CHSHa10); AF531034
TGa05); AF531043 (DEBAb91); AF531037 (DEBAd58);
96343 (DEBAd59); AY196340 (DENWd60); X60725
113); EF154083 (GBI84); D67052 (JN-BR1); EF154045
13); EF154046 (PN16); AB010401 (PTH-BM3);
54053 (WST01); EF154076 (WST05); D37813 (Sendai
U02404 (USCAlemy_01A); U02411 (USCAtt_01A);
403 (hnky12); U02410 (sam01); U02413 (tt09);
417 (zepy01); X69497 (Wales UK14); M36968
R); NC001 (Petaluma); AB010404 (SAP03); L00608
XON); Ca5 (DQ873717); Ca8 (DQ873719); Du1
873721); Jo5 (DQ873727); Pr3 (DQ873730). Subtype
AY221627 (CaONAB01); X69501 (M2); X69502 (M3);
418 (brny03); U02419 (boy03); U02420 (glwd03)
422 (mtex03); D84497 (Lp9); AB010397 (AICO2).
type C: AB016025 (TI1); AB016026 (TI2); AB016027
); AB016028 (TI4); U02392 (pady02); U02393
ar01); U02394 (pbar02); U02395 (pbar03); U02397
ar07). Subtype D: AB010400 (OKA01D). Subtype E:
496 (Lp3); D84498 (Lp20); D84500 (Lp24). GenBank
ession numbers for sequences generated in this study
HQ456781–HQ456827 inclusive.
esults
The sample population
Clinical blood samples were examined from 47 animals
t had been infected naturally with FIV; the cats were
er pet cats or stray cats waiting to be re-homed from
mal protection shelters. Samples were collected from
oss the UK. While the majority of samples originated
England, Scotland or Wales, a single sample came
Jersey (171069) and another from the Republic of
and (179200) (Fig. 1). Themajority of the cats (35 of 47)
re male (74%), a ﬁnding that is consistent with previous
dies demonstrating the predominant infection of male
cats by FIV (Hosie et al., 1989; Reggeti and Bienzle, 2004;
Hayward et al., 2007), and likely to be associated with
aggressive social behaviour in males increasing the risk of
transmission via biting (Natoli et al., 2005).
The ages were known for 34 of the 47 cats and these
ranged from 6 months to 16 years, with only 3 cats less
than 1 year of age. Infected cats were at different stages of
infection, with clinical signs ranging from asymptomatic to
symptomatic; clinical signs recorded on the submission
forms included lethargy, pyrexia, anaemia, stomatitis,
gingivitis, upper respiratory tract infections, urinary tract
infections and central nervous system disorders (Table 1).
3.2. Phylogenetic analysis of naturally occurring UK isolates
of FIV
A Bayesisan phylogenetic treewas generated based on a
651 nucleotide alignment of the V3-V5 region of the env
gene, comprising 47 novel sequences from naturally
occurring isolates of FIV togetherwith reference sequences
from subtypes A, B, C, D and E (Fig. 1). The tree
demonstrated that all the novel sequences fell within
subtype A with 100% posterior support, except for 171070,
which did not cluster with any of the known subtypes.
The genetic distance between any two sequences
within subtype A ranged between 0.0 and 0.365, with
distances among UK isolates (median: 0.110) being
virtually identical to those seen among non-UK subtype
A isolates worldwide (median: 0.110). These values were
lower than the divergence for other subtypes described in
previous studies (Sodora et al., 1994; Duarte and Tavares,
2006), indicating that subtype A may be less genetically
heterogeneous in comparison with other FIV subtypes.
Although the phylogenetic structure of subtype A
sequences was poorly resolved, a number of UK sequences
clustered with strong support. This included several pairs
(180140/180115; 182455/179288; 171536/171069;
171025/179466) with highly similar V3–V5 sequences,
despite having being isolated from geographically distinct
locations and regions (Fig. 1). In each case, these sample
pairs had been collected and processed on different days;
hence sample mix-up or cross-contamination was highly
unlikely. A high degree of spatial admixture among UK
sequences was also evident from the Mantel test, which
failed to reveal a positive correlation between genetic and
spatial distances (r =0.010, CI: 0.090 to 0.044;
p = 0.539).
Notably, British isolates almost never grouped with
isolates of other geographic origin; the sole exception
being amoderately supported clade that included three UK
sequences (171265/171175/172325) and two sequences
from continental Europe, DEBAD59 (Germany) and
ATVID02 (Austria).
3.3. Recombination analysis
Isolate 171070 was the only British isolate that did not
cluster within subtype A and comparisons with sequences
representative of subtypes B–E also failed to yield a
deﬁnitive match. 171070 was isolated from an adopted
feral cat and circumstantial evidence leaned towards an
A. Samman et al. / Veterinary Microbiology 150 (2011) 239–247242introduction to the UK from overseas, possibly from
Eastern Europe. Because the virus could not be assigned
to any given subtype, we postulated that 171070 may
represent a recombinant virus. While further analysis of
the sequence using RDP (recombination detection program
(Martin et al., 2010) and GeneConv (Sawyer, 1989) found
no evidence for a recombination event, bootscan analysis
suggested that 171070 may represent a recombinant of
subtypes A and C, with a putative breakpoint approxi-
mately 260 nucleotides from the start of the env sequence
(Fig. 2). Phylogenetic trees were constructed based on the
criteria of maximum likelihood for the sequences before
and after the putative breakpoint. Although the subtype A-
like sequence before the putative breakpoint that clustered
with subtype A as expected, it failed to fall within the
known subtype A. For the subtype C-like portion of the
171070 sequence, assignment was not clear as it did not
groupwith any of the known subtypes (Fig. 3). It is possible
that the latter sequence was derived from a subtype C
isolate that is distant from reference sequences used to
calculate the tree, perhaps derived from Eastern Europe.
Unfortunately, reference sequences from this region were
not available.
4. Discussion
Nucleotide sequences of the V3–V5 region of the env
gene have been used extensively in the genetic subtyping
of FIV strains as well as in molecular epidemiological
studies. Although it had been suspected that the FIV
isolates circulatingwithin the UK largely belong to subtype
A, this is the ﬁrst phylogenetic study to have been
performed in the UK. The results of the current study,
based on the sequence of 45 naturally occurring isolates of
Fig. 1. (A) Distribution of FIV isolates included in the study. Map shows the locations of the veterinary practices where blood samples from FIV infected cats
were collected. Color-coding distinguishes samples taken from the northern (orange), middle (red), or southern (magenta) part of the sampling area. Red
and magenta squares indicate samples from Dublin (Republic of Ireland) and the Isle of Jersey, respectively. Some locations are jittered to enhance their
visibility. (B) Bayesian consensus tree of FIV envV3–V5 sequences from theUK (bold font) alongwith representative sequences of FIV subgroups A–E (clades
collapsed). Posterior support values for nodes are shown above branches, values <0.85 are omitted for clarity. Colours for UK sequences as in part A. Other
subtype A sequences includedwere from continental Europe (green), USA and Canada (dark blue), South Africa (brown), Japan andNewZealand (light blue).
(For interpretation of the references to color in the ﬁgure caption, the reader is referred to the web version of the article.)
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A. Samman et al. / Veterinary Microbiology 150 (2011) 239–247 243from across the UK, conﬁrm that subtype A pre-
inates. The diversity of subtype A viruses is thereby
arkably high in the UK, rivaling levels of diversity seen
this subtype at a global scale. This suggests a large
ber of independent introductions of the virus into the
. At the same time, phylogenetic resolution of the V3–V5
uences was relatively poor, precluding insights regard-
the possible geographic sources of these introductions
ell as introductions into other countries from the UK.
Within the UK itself, the virus population appears to be
hly admixed, as no relationship between spatial and
etic distances was apparent from the data. The absence
patial clustering, likely a consequence of high human
bility, suggests that any new virus subtype being
introduced into the UK has the potential to quickly become
spatially disseminated. This also includes neighbouring
areas, as two of our sequences, originating from Ireland
and Jersey, exhibited very limited genetic divergence from
strains circulating within the British mainland.
As the only exception to the dominance of subtype A,
isolate 171070 was identiﬁed as a possible A/C recombi-
nant. This virus was isolated from a feral cat that had been
adopted in a suburb near a sea port, raising the possibility
that the cat had originated from outside the UK. According
to statistics published by the Department for Environment
Food and Rural Affairs (DEFRA), 74786 cats entered the UK
from 2000 to 2010 under the Pet Travel Scheme (PETS), the
system that allows pet dogs, cats and ferrets from a range
le 1
ils and clinical signs of the naturally FIV-infected cats included in the study.
rain Location Age Gender Health status Clinical signs Subtype
0003 Essex 2–3 years Male NK NK A
0141 Kent 12 years Male NK NK A
0186 Norfolk 15 years Male Sick Anaemia A
0305 Suffolk NK Female NK NK A
0338 Essex 11 years Male Sick NK A
0415 Lincolnshire Adult Male NK Covered in scabs and scars A
0418 London 1 year Male NK NK A
0488 Kent 4 years Male NK Pallid, poor condition A
0617 London Adult Female Sick NA A
0719 London 9 years Male Sick Anaemia – dehydration A
1025 London 2.5 years Male NK NK A
1069 Jersey NK Male Healthy No lesions apparent A
1070 Worcestershire 8 years Male Sick Ulcerative pharyngitis A/C
1101 London 6 months Male Sick Alopecia A
1163 Leicester 9 months Female Sick Cyclical pyrexia A
1169 Cornwall 1.5 years Female Healthy Slight conjunctivitis A
1170 Lancashire Adult Male Healthy No lesions apparent A
1175 Norfolk 16 years Female Sick Upper respiratory tract signs A
1265 Nottinghamshire NK Male Healthy No lesions apparent A
1270 Cheshire 3 years Male Healthy No lesions apparent A
1303 Norfolk Adult Male Sick NK A
1358 Lanark 16 years Male Sick Persistant non-regenerative anaemia,
leucopenia
A
1532 Cumbria 5 years Male Sick Recurrent gingivitis/stomatitis A
1700 Hull NK Male NK NK A
1781 Norfolk 10 years Male Sick Anorexia, recurrent gingivitis A
1810 Lancashire NK Female Sick Change of coat color A
1812 Norfolk 5 years Male Healthy No lesions apparent A
1838 Glasgow 1.5 years Female Sick Dullness, inappetance A
2325 London 12 years Female NK NK A
2458 Wirral 4 years Male Sick Gingivitis – stomatitis A
2506 Hull 10 years Male Sick NK A
2527 Glasgow 9 years Female Sick Ataxia A
2532 Essex NK Male NK NK A
8586 Manchester 5 years Female Sick Severe gingivitis A
8721 Lancashire 4–5 years Male Sick Large abscess on face A
9200 Dublin/Ireland 10 years Male Sick Weight loss, lethargy, fever A
9288 Lancashire 3 years Male Sick Mild gingivitis, neck lesions A
9297 Norfolk 8 years Male Healthy No lesions apparent A
9369 Hertfordshire Adult Male NK NK A
9466 Worcestershire 5 years Male NK NK A
0115 Dewsbury 12 years Female Sick Mucopurulent ocular and nasal discharges,
stomatitis, bilateral conjunctivitis
A
0140 London Adult Male Healthy No lesions apparent A
0260 Denbigh 10 years Male NK NK A
0638 Durham >2 years Male Sick Severe periodontitis, swollen and lysed jaw bones A
2309 Hull 9 years Male Sick Inappetance – halitosis A
2455 Bridgend NK Female NK NK A
6394 Kent 11 years Male Sick Urinary tract infection A
not known.
A. Samman et al. / Veterinary Microbiology 150 (2011) 239–247244of European Union (EU) and non-EU countries to enter the
UK providing they have been microchipped, vaccinated
against rabies and blood tested, and treated for ticks and
tapeworms. Cats are not tested for FIV prior to entry into
the UK, therefore, animals from areas of the world known
to harbour subtype C FIVs, e.g. the USA, may enter the UK
provided they have met the requirements for entry under
the PETS scheme. The subtype A-like part of the 171070
sequence grouped with, but did not fall within, the known
UK viruses (Fig. 3). Therefore, while the speciﬁc origin of
the putative recombinant is not clear, our results suggest
that the recombination event did not involve UK viruses
and thus likely took place prior to the virus’ introduction
into the country. Since a potential subtype A parent
sequence was not found in our data set, it is also unlikely
that recombination arose via PCR-mediated recombina-
tion. Furthermore, the high ﬁdelity DNA polymerase used
to amplify the env gene has a low error rate and overcomes
many of the limitations of Taq polymerase (Gilje et al.,
2008). Interestingly, the position of the putative break-
point for 171070 (approximately at position 265) was
similar to that reported for isolate 214 from New Zealand
(Hayward et al., 2007), which could indicate that this site is
a recombination hotspot within env V3–V5. Hence it
appears likely that this is the ﬁrst isolation of a subtype C-
like isolate of FIV from either the UK or Western Europe.
Reviewing the NCBI database conﬁrmed that no FIV
sequences from Eastern Europe were available for com-
parison.
Is the predominance of a subtype A in the UK
unexpected? It is likely that the dominant subtypes of
FIV around the world were established many years ago
among geographically isolated populations of cats and
may represent multiple introductions of FIV into the cat
population. Previous studies have hinted that subtype A
viruses may predominate not only in the UK, but in the
west of Europe per se, in the UK, France, The Netherlands
and Switzerland, while subtype B viruses are more
common towards the east and south of Europe in Portugal,
Italy and Germany (Pistello et al., 1997; Steinrigl and
Klein, 2003; Duarte and Tavares, 2006; Steinrigl et al.,
2010). Accordingly, the presence of subtype B viruses has
been conﬁrmed recently in Turkey (Oguzoglu et al., 2010).
Given the physical separation of the UK from mainland
Europe, and its nearest neighbors also having subtype A
viruses in circulation, the FIV subtypes in the UK cat
population may have remained relatively free from the
introduction of novel subtypes. The presence of a subtype
C recombinant in the UK would suggest a non-European
country of origin. The advent ofmore frequent transport of
cats in and out of the UK under the PETS scheme will
increase the likelihood of introducing novel subtypes into
the UK. Given the prevalence of FIV in the UK is estimated
at approximately 5% (Hosie et al., 1989) and the total cat
population at approximately 11 million, this would
equate to approximately 550,000 FIV-positive cats in
the UK. In comparison, in the USA, the prevalence of FIV
has been recorded at 2.5% across North America (Levy
et al., 2006),while approaching 3.6% in the southern states
of Louisiana,Mississippi and Texas (Levy et al., 2007). Ifwe
were to consider an extreme scenario whereby all the cats
entering the UK were to come from a country such as the
USA where subtype C was present, assuming no other
biases (for example differences in transmission rates),
over a ten year periodwith 74,786 introductions only 2.5%
or approximately 1870 FIV positive cats would enter the
UK; 1870 FIV positive cats added to the existing 550,000
subtype A positive cats (0.34%). Thus, in extremis, we
might expect to detect one novel introduced subtype in
approximately every 300 cats sampled. Our study
examined 47 FIV-positive cats, it is therefore somewhat
fortuitous that we detected the novel A/C recombinant.
This theoretical consideration does emphasise that it may
take a considerable time for the composition of subtypes
in the UK to alter.
Since Env, the major target for virus neutralization,
displays immense diversity, it has been proposed that it
may be necessary to develop regional vaccines that are
each based on the sequence of the predominant circulating
viruses in particular regions or countries, at least as a
preliminary controlling measure (Pistello et al., 1997;
Steinrigl and Klein, 2003). There is some evidence that
protection can be achieved against an intra-subtype B
heterologous FIV challenge using an attenuated FIV
vaccine (Pistello et al., 2003). However this trial was
conducted solely with FIV isolates from subtype B and this
ﬁnding has not been reproduced in trials involving other
subtypes or in a wider geographical area. It has been
suggested that subtype B isolatesmay bemore ancient and
host adapted and as a consequence may be less virulent
(Bachmann et al., 1997). In countries where a more
heterogeneous FIV population exists, an effective vaccine
would be required to protect against diverse strains which
may belong to more than one subtype. Moreover, in such
circumstances, recombination between FIV isolates of
different subtypesmay occur as a result of co-infection and
Fig. 2. Bootscan analysis of env V3–V5 from 171070. Bootscan analysis
was performed using a window of 200 nucleotides and a step of 20
nucleotides, under a F84 model with empirical transition/transversion
ratio and 1000 bootstrap replicates. Strain 171070 was used as a query in
the analysis relative to the subtypes A–E consensus sequences. Horizontal
line shows the 70% bootstrap cut-off.
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A. Samman et al. / Veterinary Microbiology 150 (2011) 239–247 245ult in chimaeric strains which may be resistant to
cine-induced protection. Our results suggest that such a
nario is less likely for the UK, which appears to be
ngly dominated by subtype A virus and thus may a
suitable area for a subtype A vaccine trial, should such a
vaccine become available.
In conclusion, this study has demonstrated that FIV
subtype A, if not exclusively the circulating subtype,
3. Maximum likelihood phylogenetic trees based on the nucleotide sequence of the A/C recombinant 171070 from (A) 50 terminus to putative
kpoint sequence, and (B) breakpoint to the end of the sequence. Bootstrap frequencies of 50% ormore are shown at themain nodes. Branches are shown
d for subtype A reference sequences, blue for subtype B reference sequences, green for subtype C reference sequences, pink for subtype E reference
ence, and cyan for subtype D reference sequences. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web
ion of the article.)
A. Samman et al. / Veterinary Microbiology 150 (2011) 239–247246predominates in the UK. Further characterisation of the
genetic diversity of FIV investigating a greater number of
isolates may provide more information about whether
subtype A is the only subtype circulating within the UK,
since an A/C recombinant isolate has been recognised.
Because of the immense diversity of the virus, developing
regional or sub-type speciﬁc vaccine could be of signiﬁcant
use.
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